Screener
Kiniksa Pharmaceuticals International, plc KNSA Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $175.68M-8.5% | $189.95M+20.9% | $165.6M-9.8% | $174.86M+79.6% | $192.04M+93.4% | ||
| $350.25M+203% | $278.14M+150% | $248.48M+314% | $177.24M+40.2% | $115.75M-3.1% | ||
| $23.49M-26.4% | $23.22M-42.0% | $15.59M-62.6% | $51.74M+108% | $31.91M+56.0% | ||
| $70.93M+47.2% | $73.14M+231% | $54.9M+108% | $41.4M+44.3% | $48.18M+38.2% | ||
| $668.63M+59.1% | $594.17M+66.9% | $527.18M+58.9% | $475.53M+52.8% | $420.31M+39.6% | ||
| $2.58M+139% | $1.99M+228% | $1.94M+194% | $1.66M+195% | $1.08M+72.2% | ||
| $14.75M-6.3% | $15M-6.3% | $15.25M-6.2% | $15.5M-6.1% | $15.75M-6.0% | ||
| $896.11M+35.5% | $825.28M+37.7% | $763.63M+31.5% | $712.33M+28.3% | $661.15M+21.9% | ||
| $12.4M+38.5% | $24.4M+1,131% | $2.03M-0.5% | $6.15M-26.2% | $8.96M+21.1% | ||
| $171.25M+45.3% | $156.61M+61.0% | $139.18M+38.3% | $123.59M+28.8% | $117.83M+39.8% | ||
| $241.96M+45.6% | $219.59M+54.8% | $196.03M+37.9% | $176.95M+49.6% | $166.14M+54.8% | ||
| -$414.11M+16.3% | -$439.55M+14.3% | -$462.14M+11.3% | -$476.34M+7.0% | -$494.77M+1.0% | ||
| $654.15M+32.1% | $605.69M+32.4% | $567.61M+29.5% | $535.38M+22.5% | $495.01M+13.8% | ||
| $896.11M+35.5% | $825.28M+37.7% | $763.63M+31.5% | $712.33M+28.3% | $661.15M+21.9% |
FAQ
- What are Kiniksa Pharmaceuticals International, plc's total assets?
- Kiniksa Pharmaceuticals International, plc (KNSA) holds $896.1M in total assets, up 35.5% year over year.
- How much debt does Kiniksa Pharmaceuticals International, plc have?
- Kiniksa Pharmaceuticals International, plc carries $8.9M in total debt against $654.1M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Kiniksa Pharmaceuticals International, plc have?
- Kiniksa Pharmaceuticals International, plc holds $175.7M in cash and equivalents.
- Can Kiniksa Pharmaceuticals International, plc cover its short-term obligations?
- Its current ratio is 3.90 — current assets exceed current liabilities.
- Where does Kiniksa Pharmaceuticals International, plc's balance sheet data come from?
- Every line is extracted from Kiniksa Pharmaceuticals International, plc's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
